Skip navigation

Clarity, Guiding Strategies and Industry Benchmarking Amid Program Change and Policy Uncertainty

May 19-21, 2020
  • Orlando, FL

In light of ongoing uncertainty in the healthcare landscape, MDRP and GP execs are asking many questions about the future of Medicaid and evolving government pricing and reporting requirements. Effectively navigating the political and regulatory landscape while simultaneously managing the increasing demands of GP reporting is critical to overall success.

CBI’s 22nd Annual Medicaid and Government Pricing Congress is built off of the changing dynamics within the pharmaceutical landscape and arms attendees with action-oriented discussions and implementable takeaways on a full range of content including state pricing transparency, Medicare reform, value-based frameworks, 340B, supplemental rebates, reasonable assumptions and much more.

Benefit from In-Depth
Sessions on Critical Topics:

  • Implications of a World Without Rebates
  • State Invoicing and Dispute Resolution
  • Federal Contracting and FSS
  • 340B Program Evolution and Oversight
  • Value-Based Contracting and GP Considerations
  • State Drug Pricing Transparency
  • Changes within the Medicare Landscape
  • Product Launch Strategies and Considerations
  • 340B Duplicate Medicaid and Commercial Rebates
  • Gross-to-Net and Accruals for Medicaid
  • Impact of CPIU URA Penalty on Generic Manufacturers

PREVIOUS ATTENDEES ACCLAIM:

This conference is amazing!! Extremely knowledgeable speakers providing a wealth of information. This conference is a must for anyone involved in any part of the GP space.

Manager, Government Pricing and Reimbursement, Arbor Pharmaceuticals

CBI’s Medicaid and Government Pricing Congress is a
great networking and learning experience that
serves the beginner through expert.

VP, Sales, Pricing & Contract Solutions, Fresenius Medical Care North America

Excellent content and subject matter experts along with
great networking and benchmarking opportunities.

Executive Director, Contract Operations and Government Pricing, Sandoz

Up to the minute updates, informative and great speakers. Conference is great for beginners to experts. I can
always take something from this conference and
enjoy the networking opportunities.

Director, Commercial Operations, Helsinn Therapeutics (U.S.), Inc.

CBI’s Medicaid Congress gave me renewed energy to go back and work on tightening up our GP methods, WI, SOPs and decision trees. Great ideas, great collaboration.

Associate Director, Vertex Pharmaceuticals
Reach Out to the #OrlandoMedicaid Team to Get Involved:
Medicaid team contacts
Stay Connected and Join the Conversation:

Medicaid and Government Pricing Congress 2020

Clarity, Guiding Strategies and Industry Benchmarking Amid Program Change and Policy Uncertainty

In light of ongoing uncertainty in the healthcare landscape, MDRP and GP execs are asking many questions about the future of Medicaid and evolving government pricing and reporting requirements. Effectively navigating the political and regulatory landscape while simultaneously managing the increasing demands of GP reporting is critical to overall success.

CBI’s 22nd Annual Medicaid and Government Pricing Congress is built off of the changing dynamics within the pharmaceutical landscape and arms attendees with action-oriented discussions and implementable takeaways on a full range of content including state pricing transparency, Medicare reform, value-based frameworks, 340B, supplemental rebates, reasonable assumptions and much more.

Benefit from In-Depth
Sessions on Critical Topics:

  • Implications of a World Without Rebates
  • State Invoicing and Dispute Resolution
  • Federal Contracting and FSS
  • 340B Program Evolution and Oversight
  • Value-Based Contracting and GP Considerations
  • State Drug Pricing Transparency
  • Changes within the Medicare Landscape
  • Product Launch Strategies and Considerations
  • 340B Duplicate Medicaid and Commercial Rebates
  • Gross-to-Net and Accruals for Medicaid
  • Impact of CPIU URA Penalty on Generic Manufacturers

PREVIOUS ATTENDEES ACCLAIM:

This conference is amazing!! Extremely knowledgeable speakers providing a wealth of information. This conference is a must for anyone involved in any part of the GP space.

Manager, Government Pricing and Reimbursement, Arbor Pharmaceuticals

CBI’s Medicaid and Government Pricing Congress is a
great networking and learning experience that
serves the beginner through expert.

VP, Sales, Pricing & Contract Solutions, Fresenius Medical Care North America

Excellent content and subject matter experts along with
great networking and benchmarking opportunities.

Executive Director, Contract Operations and Government Pricing, Sandoz

Up to the minute updates, informative and great speakers. Conference is great for beginners to experts. I can
always take something from this conference and
enjoy the networking opportunities.

Director, Commercial Operations, Helsinn Therapeutics (U.S.), Inc.

CBI’s Medicaid Congress gave me renewed energy to go back and work on tightening up our GP methods, WI, SOPs and decision trees. Great ideas, great collaboration.

Associate Director, Vertex Pharmaceuticals
Reach Out to the #OrlandoMedicaid Team to Get Involved:
Medicaid team contacts
Stay Connected and Join the Conversation: